「新輔助激素治療的反應及影響」 (The implications of response in neoadjuvant hormonal therapy)。
2017 Taipei International Breast Cancer Symposium 會議於9月29~10月1日於台北市舉辦國際乳癌學術研討會，來自世界各地包括美國、義大利、澳洲、日本等多國地區的乳癌治療專家學者，分享臨床研究的最新進展、免疫治療和個性化精密醫學腫瘤領域的話題。癌轉譯研究組織執行總監，香港仁康醫療乳腺綜合診治中心周永昌教授，分享研討議題「新輔助激素治療的反應及影響」(The implications of response in neoadjuvant hormonal therapy)。
Louis Wing-Cheong Chow, M.B.B.S, M.S.
Distinguished Professor, Macau University of Science and Technology, Macau Executive Directive, organization for Oncology and Translational Research(OOTR) Medical Director, UNIMED Medical Institute, Hong Kong, China
Louis WC Chow is the Executive Director of the Organization tar Oncology and Translational Research in Hong Kong, a distinguished professor of Macau University of Science and Technology the Medical Director of the Comprehensive Centre for Breast Diseases at the UNIMED Medical Institute in Hong Kong, an honorary professor of the Third Military Medical University an honorary professor at Ningxia Medical College School of Clinical Medicine in Ningxia, China; an honorary professor at Tohoku University in Sendai, Japan, a visiting professor at Wuhan University of Science and Technology and an honorary consultant of Kiang Wu Hospital in Macau. Professor Chow was a former honorary clinical professor of the clinical trials centre at The University of Hong Kong, former president of the Asian Breast Cancer Society, and former honorary secretary of The Hong Kong Academy of Medicine.
Professor Chow received his medical education at The University of Hong Kong and completed is residency at the Queen Mary and Kwong Wah Hospitals in Hong Kong He then underwent sabbatical training at the Memorial Sloan-Kettering Cancer Center in New York, Yale University New Haven, Connecticut, and the University of Southern California in Los Angeles After training in surgical oncology, Professor Chow returned to The University of Hong Kong and held competitive positions of assistant and associate professors in the department of surgery of the university. During his professorship, he gave lectures to medical and nursing students and staff on breast cancer surgical and medical treatments, and directed the radio-guided surgery courses for breast university. Apart from his clinical and cancer and a minimally invasive breast biopsy course a teaching duties, he also served as Associate Dean of the Faculty of Medicine, Deputy Director of the Centre of Education and Training in the department of surgery, and examiner for postgraduate examinations as well as supervisor of doctorate and master degree students As Associate Dean Professor Chow played a pivotal role in the adoption of the problem-based learning (PBL curriculum into the School of Medicine, which encourages analytical and critical thinking for complex subjects. This instrumental step was forefront for the development of PBL throughout all faculties of the University.
Professor Chow is a Fellow of the Royal College of Surgeons, a Fellow of the College of Surgeons of Hong Kong, and a Fellow of the American Cancer Society. He is also an expert in cancer research and has obtained a patent on a mouse cell line derived from human malignant cystosarcoma phylloides. In the past few years, he has obtained various research and professional grants for cancer research purposes in the university and contributed as Principal Investigator Coinvestigator of several international clinical trials. Professor Chow has published more than 190 articles in peer-reviewed journals. His research interests are breast cancer molecular therapy, chemoresistance, chemoprevention and translational research in breast cancer
At the 6th National Breast Cancer Forum held in Chongqing of December 2012, Professor Chow was awarded the prestigious research prize of Kim Hyun-Jib Breast Cancer Research Memorial Award. Professor Chow is the only recipient in Hong Kong and Macau to have been bestowed with this honor.